FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tapani Luukkainen

Research Profile

Chemicals & Drugs

Devices

Physiology

Phenomena

Intrauterine Device Expulsion

Anatomy

Endometrium

Disorders

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Päivi Pakarinen; Tapani Luukkainen
Treatment of menorrhagia with an LNG-IUS.
Päivi Pakarinen; Tapani Luukkainen
Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
Tapani Luukkainen
Issues to debate on the Women's Health Initiative: failure of estrogen plus progestin therapy for prevention of breast cancer risk.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tapani Luukkainen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Päivi Pakarinen; Tapani Luukkainen
Treatment of menorrhagia with an LNG-IUS.
Contraception 2007;75(6 Suppl):S118-22.
2005: Päivi Pakarinen; Tapani Luukkainen
Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
Contraception 2005;72(5):342-5.
2003: Tapani Luukkainen
Issues to debate on the Women's Health Initiative: failure of estrogen plus progestin therapy for prevention of breast cancer risk.
Human reproduction (Oxford, England) 2003;18(8):1559-61.
2003: Päivi Pakarinen; Juhani Toivonen; Tapani Luukkainen
Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up.
Contraception 2003;68(1):31-4.
2001: Päivi Pakarinen; Juhani Toivonen; Tapani Luukkainen
Therapeutic use of the LNG IUS, and counseling.
Seminars in reproductive medicine 2001;19(4):365-72.
2001: Tapani Luukkainen; Päivi Pakarinen; Juhani Toivonen
Progestin-releasing intrauterine systems.
Seminars in reproductive medicine 2001;19(4):355-63.
2000: Tapani Luukkainen
The levonorgestrel intrauterine system: therapeutic aspects.
Steroids 2000;65(10-11):699-702.
1997: Päivi Pakarinen; J Suvisaari; Tapani Luukkainen; Pekka Lähteenmäki
Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Fertility and sterility 1997;68(1):59-64.
1997: Tapani Luukkainen
[Contraception in the next millenium].
Duodecim; lääketieteellinen aikakauskirja 1997;113(12):1165-6.
1997: Juhani Toivonen; Tapani Luukkainen
Progestin-releasing intrauterine devices.
Current therapy in endocrinology and metabolism 1997;6():281-5.
1996: Päivi Pakarinen; Tapani Luukkainen; Kaisa Elomaa; K Ratsula; P Venesmaa; J Tuominen; Pekka Lähteenmäki
A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal.
Contraception 1996;54(3):187-92.
1995: Tapani Luukkainen; Juhani Toivonen
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Contraception 1995;52(5):269-76.
1995: Päivi Pakarinen; Tapani Luukkainen; H Laine; Pekka Lähteenmäki
The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation.
Human reproduction (Oxford, England) 1995;10(9):2390-4.
1993: R Kekkonen; Pekka Lähteenmäki; Tapani Luukkainen; J Tuominen
Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Fertility and sterility 1993;60(4):610-5.
1992: Tapani Luukkainen
Contraception after thirty-five.
Acta obstetricia et gynecologica Scandinavica 1992;71(3):169-74.
1992: Tapani Luukkainen
[Health benefits of contraception].
Duodecim; lääketieteellinen aikakauskirja 1992;108(23-24):2083-7.
1991: Juhani Toivonen; Tapani Luukkainen; H Allonen
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Obstetrics and gynecology 1991;77(2):261-4.
1991: Tapani Luukkainen
Levonorgestrel-releasing intrauterine device.
Annals of the New York Academy of Sciences 1991;626():43-9.
1991: Pekka Lähteenmäki; Rochelle N Shain; K Ratsula; Juhani Toivonen; Alan EC Holden; M Rosenthal; Tapani Luukkainen
[One year experience of levonorgestrel-releasing intrauterine device].
Duodecim; lääketieteellinen aikakauskirja 1991;107(1):26-31.
1990: Tapani Luukkainen; Pekka Lähteenmäki; Juhani Toivonen
Levonorgestrel-releasing intrauterine device.
Annals of medicine 1990;22(2):85-90.
1990: R Kekkonen; Henrik Alfthan; Maija Haukkamaa; Oskari Heikinheimo; Tapani Luukkainen; Pekka Lähteenmäki
Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Fertility and sterility 1990;53(4):747-50.
1989: K Ratsula; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
Contraception 1989;39(2):195-204.
1989: Rochelle N Shain; K Ratsula; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen; Alan EC Holden; M Rosenthal
Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Contraception 1989;39(1):73-84.
1988: Tapani Luukkainen; Oskari Heikinheimo; Maija Haukkamaa; Pekka Lähteenmäki
Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Fertility and sterility 1988;49(6):961-3.
1987: Oskari Heikinheimo; H Croxatto; Ana Maria Salvatierra; C C Chang; Tapani Luukkainen; Pekka Lähteenmäki
Intravaginal administration of RU 486 in humans and rats: inadequate absorption in humans.
Human reproduction (Oxford, England) 1987;2(8):645-8.
1987: Tapani Luukkainen; H Allonen; Maija Haukkamaa; P Holma; T Pyörälä; J Terho; Juhani Toivonen; I Batar; L Lampe; K Andersson
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Contraception 1987;36(2):169-79.
1987: Oskari Heikinheimo; Pekka Lähteenmäki; Erkki Koivunen; D Shoupe; H Croxatto; Tapani Luukkainen; P Lähteenmäki
Metabolism and serum binding of RU 486 in women after various single doses.
Human reproduction (Oxford, England) 1987;2(5):379-85.
1987: Oskari Heikinheimo; K Kontula; H Croxatto; I Spitz; Tapani Luukkainen; Pekka Lähteenmäki
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.
Journal of steroid biochemistry 1987;26(2):279-84.
1987: Pekka Lähteenmäki; Oskari Heikinheimo; H Croxatto; I Spitz; D Shoupe; L Birgerson; Tapani Luukkainen
Pharmacokinetics and metabolism of RU 486.
Journal of steroid biochemistry 1987;27(4-6):859-63.
1987: Juhani Toivonen; Tapani Luukkainen
[Contraceptive coils and their problems].
Duodecim; lääketieteellinen aikakauskirja 1987;103(9):546-51.
1986: Tapani Luukkainen; H Allonen; Maija Haukkamaa; Pekka Lähteenmäki; C G Nilsson; Juhani Toivonen
Five years' experience with levonorgestrel-releasing IUDs.
Contraception 1986;33(2):139-48.
1986: Steven G Silverberg; Maija Haukkamaa; H Arko; C G Nilsson; Tapani Luukkainen
Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1986;5(3):235-41.
1985: H Kurunmäki; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules.
Contraception 1985;31(3):305-18.
1984: H Kurunmäki; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
Contraception 1984;30(5):431-42.
1984: Pekka Lähteenmäki; H Kurunmäki; P Lähteenmäki; Juhani Toivonen; Tapani Luukkainen
Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginally.
Contraception 1984;30(4):381-9.
1984: H Allonen; Tapani Luukkainen; N C Nielsen; K G Nygren; T Pyörälä
Factors affecting the clinical performance of Nova T and Copper T 200.
Obstetrics and gynecology 1984;64(4):524-9.
1984: H Kurunmäki; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Intracervical release of ST-1435 for contraception.
Contraception 1984;29(5):411-21.
1984: H Kurunmäki; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device.
Contraception 1984;29(1):31-43.
1984: C G Nilsson; P L Lähteenmäki; Tapani Luukkainen
Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
Fertility and sterility 1984;41(1):52-5.
1983: Tapani Luukkainen; H Allonen; N C Nielsen; K G Nygren; T Pyörälä
Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
American journal of obstetrics and gynecology 1983;147(8):885-92.
1983: K G Nygren; H Allonen; N C Nielsen; Tapani Luukkainen; T Pyorala
[Nova-T and Copper-T 200 in a five year's clinical comparison].
Contraception, fertilité, sexualité 1983;11(11):1179-84.
1983: K Ratsula; Maija Haukkamaa; K Wichmann; Tapani Luukkainen
Vaginal contraception with gossypol: a clinical study.
Contraception 1983;27(6):571-6.
1983: P L Lähteenmäki; G L Hammond; Tapani Luukkainen
Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities.
Acta endocrinologica 1983;102(2):307-13.
1982: C G Nilsson; Maija Haukkamaa; H Vierola; Tapani Luukkainen
Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.
Clinical endocrinology 1982;17(6):529-36.
1982: M Heikkilä; P Nylander; Tapani Luukkainen
Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device.
Contraception 1982;26(5):465-74.
1982: G L Hammond; P L Lähteenmäki; P Lähteenmäki; Tapani Luukkainen
Distribution and percentages of non-protein bound contraceptive steroids in human serum.
Journal of steroid biochemistry 1982;17(4):375-80.
1982: M Heikkilä; P Lähteenmäki; Tapani Luukkainen
Immediate postabortal insertion of a levonorgestrel-releasing IUD.
Contraception 1982;26(3):245-59.
1982: T Pyörälä; H Allonen; K G Nygren; N C Nielsen; Tapani Luukkainen
Return of fertility after the removal of Nova T or copper T 200.
Contraception 1982;26(2):113-20.
1982: N C Nielsen; T Pyörälä; H Allonen; K G Nygren; Tapani Luukkainen
Four years of a comparative study with Nova T and Copper T 200 IUDS.
Contraception 1982;26(1):29-40.
1982: M Heikkilä; Tapani Luukkainen
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Contraception 1982;25(3):279-92.
1982: K Wichmann; A Vaheri; Tapani Luukkainen
Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent.
American journal of obstetrics and gynecology 1982;142(5):593-4.
1982: M Heikkilä; Maija Haukkamaa; Tapani Luukkainen
Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.
Contraception 1982;25(1):41-9.
1981: K G Nygren; N C Nielsen; T Pyörälä; H Allonen; Tapani Luukkainen
Intrauterine contraception with Nova-T and copper-T-200 during three years.
Contraception 1981;24(5):529-42.
1981: H Kurunmäki; Juhani Toivonen; Pekka Lähteenmäki; Tapani Luukkainen
Intracervical release of levonorgestrel for contraception.
Contraception 1981;23(5):473-85.
1980: S Sipinen; Pekka Lähteenmäki; Tapani Luukkainen
An oestrone-releasing vaginal ring in the treatment of climacteric women.
Maturitas 1980;2(4):291-9.
1980: H Allonen; Tapani Luukkainen; N C Nielsen; K G Nygren; T Pyorala
[Comparative results on two years use of Nova T and Copper T].
Contraception, fertilité, sexualité 1980;8(10):751-8.
1980: S Sipinen; Pekka Lähteenmäki; Tapani Luukkainen
Silastic implants releasing estrone in the treatment of climacteric complaints.
Maturitas 1980;2(3):213-24.
1980: Pekka Lähteenmäki; P Ylöstalo; S Sipinen; Juhani Toivonen; L Ruusuvaara; P Pikkola; C G Nilsson; Tapani Luukkainen
Return of ovulation after abortion and after discontinuation of oral contraceptives.
Fertility and sterility 1980;34(3):246-9.
1980: Maija Haukkamaa; C G Nilsson; Tapani Luukkainen
Screening, management, and outcome of pregnancy in diabetic mothers.
Obstetrics and gynecology 1980;55(5):596-602.
1980: H Pösö; K Wichmann; J Jänne; Tapani Luukkainen
Gossypol, a powerful inhibitor of human spermatozoal metabolism.
Lancet 1980;1(8173):885-6.
1980: H Allonen; Tapani Luukkainen; N C Nielsen; K G Nygren; T Pyörälä
Two-year rates for Nova T and Copper T in a comparative study.
Contraception 1980;21(4):321-34.
1980: S Sipinen; Pekka Lähteenmäki; Tapani Luukkainen
Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Acta obstetricia et gynecologica Scandinavica 1980;59(2):149-53.